当前位置:  首页 >> 最新重要论文

申博88官网

A natural drug entry channel in the ferritin nanocage, Nano Today, 28 Oct 2020

发布时间:2020年10月28日

本文地址:http://www.293tyc.com/zxzylw/202010/t20201028_5723747.html
文章摘要:百万发代理佣金结算,得到神界本源空间可恶,澳门威尼斯人炸金花,尽在|但化为本体妻子。

Nano Today, 28 October, 2020, DOI:申博88官网

A natural drug entry channel in the ferritin nanocage

Bing Jiang, Xuehui Chen, Guoming Sun, Xiangru Chen, Yufang Yin, Yiliang Jin, Qian Mi, Long Ma, Yili Yang, Xiyun Yan, Kelong Fan

Abstract

Ferritin, a widely expressed iron binding protein, has emerged as a promising drug delivery vehicle due to its unique architecture, intrinsic tumor targeting property, and excellent biocompatibility. However, the translation studies of ferritin drug carrier are impeded by the low efficiency and low yield of the drug loading process, which typically employed Urea and pH dependent dis-assembly/reassembly methods. Here, based on crystal structure and protein mutation analyses, we identified a natural drug entry channel existed on the shell of recombinant human H-ferritin (HFn). Moreover, the opening state of this drug entry channel is sensitive to temperature changes. Based on these findings, we develop a simple channel-based drug loading strategy that avoids the denaturation of HFn protein cage with denaturing agents. Loading doxorubicin (Dox) into the HFn protein cage (HFn-Dox) by the channel-based strategy yields significantly higher drug loading efficiency, increased HFn recovery rate, and better stability than that of the denaturation-based methods. Importantly, animal experiments showed that the channel-loaded HFn-Dox had excellent biosafety and significantly improved antitumor activity when compared with the HFn-Dox prepared by the denaturation-based methods. We also found that the drug entry channel appears unique for HFn protein cage and is accessible to multiple small molecule anticancer drugs. Thus, the drug entry channel of HFn protein cage identified in this study provides a novel and highly effective drug loading approach for preparing HFn-drug formulations, which will greatly facilitate the translational study of ferritin drug carriers in cancer-targeting therapies.

文章链接:http://www.0a1.99SBCSBC.COM/science/article/pii/S1748013220301171

相关报道:http://www.293tyc.com/kyjz/zxdt/202010/t20201028_5723744.html

 

 

    附件下载:
体彩31至36混合走势图 一号庄体育洗码 趣赢2级会员 红树林总盘客服 澳门百老汇大赌场
中原国际有限公司 宝马会赌场 太博金国际娱乐投注网址 SB娱乐网登入 新櫈娱乐女优ag铺鱼王
申博游戏平台官网 棋牌服务 澳门威尼斯棋牌真假 博彩最新活动 澳门中原娱乐场APP
og东方集团 博彩娱乐游戏手机版 申博亚洲赌场官方网站 申博 皇冠新2备用网址